Genentech has been saying for years that it has confidence in a supercharged version of its hit breast cancer drug, and today it cleared a major hurdle on the way to making it a reality.

Genentech, ImmunoGen ‘Smart Bomb’ for Breast Cancer Clears Big Hurdle | Xconomy